Examining the risk factors for trastuzumab-related cardiotoxicity in a predominantly Hispanic South Texas population: A descriptive study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

As a class, sodium–glucose transporter 2 inhibitors are novel drugs initially developed for glycemic control in patients with type 2 diabetes. [Cowie MR, et al. Nat Rev Cardiol. 2020;1a] Their primary ...

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

In a recent study published in the European Heart Journal, researchers assessed the impact of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors on type 2 diabetes and heart failure (HF) ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose ...

Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. (HealthDay News) — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent ...

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and ...

TCT 1128: Transcatheter Edge-to-Edge versus Surgical Repair for Primary Mitral Regurgitation: Nationwide Utilization, In-Hospital Outcomes, and Costs in the 2022 National Inpatient Sample Receive the ...

wound of ankle gout patient Researchers studied the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and gout, using a cohort study design and a symmetry analysis. The use of ...